The one idea that changed how I think about Alzheimer's
For most of the last century, Alzheimer's disease has been understood as a single condition with a single cause. Find the cause, develop the drug, cure the disease. It is a logical framework. It is also, the evidence increasingly suggests, the wrong one.
The idea that changed how I think about Alzheimer's is simple but profound: it is not one disease. It is many. And that changes everything about how we approach it.
The 36 holes in the roof
Dr Dale Bredesen, the neuroscientist behind the ReCODE protocol, uses a striking analogy. Imagine a roof with 36 holes in it. If you patch one hole, rain still gets in through the other 35. No single fix solves the problem. The only solution is to identify all the holes and address them systematically.
Alzheimer's disease, Bredesen argues, works the same way. It is driven not by a single pathological process but by dozens of contributing factors acting simultaneously: chronic inflammation, insulin resistance, toxin accumulation, hormonal decline, nutritional deficiencies, sleep disruption, cardiovascular risk, and more.
Amyloid, the protein that has been the primary target of pharmaceutical research, is not simply a rogue molecule causing damage. It appears to be a protective response to these underlying threats. Remove the threats, and the amyloid burden reduces. This reframing has significant implications for how we think about prevention and treatment.
Why this matters for you
If Alzheimer's has 36 contributing factors, there are 36 places to intervene. That is not a reason to feel overwhelmed. It is a reason to feel agency.
Many of the factors that drive cognitive decline are modifiable: the food you eat, the quality of your sleep, your exposure to environmental toxins, the way you manage stress, your cardiovascular health, your hormone balance. These are not peripheral lifestyle considerations. They are neurological inputs. They shape, measurably, the health of your brain.
This does not mean that everyone who addresses these factors will prevent dementia. Genetics play a role. Timing matters. But for the majority of people, particularly those acting before significant symptoms appear, the evidence for meaningful intervention is compelling.
The shift from passive to active
The conventional model of dementia care asks patients to wait for symptoms, receive a diagnosis, and manage decline. The emerging model asks something different: understand your risk, identify your specific drivers, and take targeted action before the window closes.
That shift, from passive acceptance to informed agency, is what the science increasingly supports. And it is a shift that is available to anyone willing to ask the right questions.